Aquagenic urticaria likely has a genetic component, but no specific gene mutation has been identified. The vast majority of cases appear sporadically, meaning they show up in people with no family history of the condition. However, a small number of familial cases documented in medical literature, along with a striking case in identical twins, suggest that genetics play at least a partial role.
What the Familial Cases Tell Us
With fewer than 100 cases documented worldwide, aquagenic urticaria is extraordinarily rare, which makes studying its genetics difficult. Most people who develop it have no relatives with the condition. But scattered through the medical literature are several family clusters that hint at hereditary influence.
One well-documented case involved a male patient whose grandmother, mother, aunt, and cousin all had aquagenic urticaria, spanning three generations. That same family also shared familial lactose intolerance, raising the question of whether the two conditions might be linked through nearby genes. In another case, three sisters all developed aquagenic urticaria alongside a rare inherited bleeding disorder called Bernard-Soulier syndrome. Researchers speculated the conditions might share overlapping genetic regions on chromosomes 17, 22, and 3, though they acknowledged it could also be coincidence.
Perhaps the strongest evidence comes from a case of identical twins who both developed aquagenic urticaria. Because identical twins share virtually all their DNA, this was considered the most direct support yet for a genetic component. It was the first documented case of its kind.
Why No Gene Has Been Found
Despite these familial patterns, researchers have not pinpointed a specific mutation responsible for aquagenic urticaria. The condition is so rare that large-scale genetic studies, the kind that identify gene variants across hundreds or thousands of patients, simply aren’t feasible. Most of what’s known comes from individual case reports and small family clusters.
The underlying mechanism itself remains poorly understood. The leading theory is that water interacts with a substance in or on the skin to produce a compound that triggers mast cells (the immune cells responsible for hives). But exactly why some people’s skin reacts this way, and whether that sensitivity is coded in their DNA or develops through other factors, is still an open question. The condition doesn’t follow a clear inheritance pattern like autosomal dominant or recessive traits, which makes genetic mapping even harder.
Who Develops Aquagenic Urticaria
A systematic review of documented cases found that aquagenic urticaria predominantly affects women, who make up about 61% of patients. The average age of onset is roughly 20 years old, though it has appeared in people as young as infancy and as late as their mid-50s. Many cases emerge during puberty or early adulthood, which has led some researchers to wonder whether hormonal changes might play a triggering role, though this hasn’t been confirmed.
How It Differs From Aquagenic Pruritus
If you’re researching water-related skin reactions, it’s worth knowing that aquagenic urticaria is distinct from aquagenic pruritus. Both involve skin reactions to water contact, but they behave differently. Aquagenic urticaria produces visible hives: raised, red, itchy welts that typically appear within minutes of water exposure. Aquagenic pruritus causes intense itching without any visible skin changes at all. The distinction matters because aquagenic pruritus can be associated with blood disorders like polycythemia vera and doesn’t respond to the same treatments.
Managing a Condition You Can’t Avoid
Since complete avoidance of water is impossible, treatment focuses on reducing symptoms. The first-line approach is second-generation antihistamines like cetirizine or fexofenadine, sometimes at higher than standard doses. Barrier creams containing ceramides can help by creating a protective layer between water and skin. Some patients also benefit from ultraviolet light therapy, either alone or alongside antihistamines.
For people who don’t respond to antihistamines, even at increased doses, a biologic injection called omalizumab has the strongest evidence for refractory cases. It works by targeting the antibody involved in allergic reactions and is given as a subcutaneous injection roughly once a month.
Day-to-day management often involves practical adjustments: keeping showers under five minutes, using wet wipes for hygiene when possible, and applying barrier creams before any expected water contact. Rain, sweat, and even tears can trigger symptoms in some patients, which makes the condition particularly disruptive to daily life. The unpredictability of flares, combined with how little is understood about the condition, can take a real psychological toll alongside the physical symptoms.